Dirk Laurent
Impact in
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 44
- Colorectal Cancer Treatments and Studies 33
- Cancer Treatment and Pharmacology 23
-
- Cancer, Lipids, and Metabolism 14
- Cancer, Hypoxia, and Metabolism 8
- Co-authors
- Eric Van Cutsem (14 shared papers)Heinz‐Josef Lenz (11 shared papers)Salvatore Siena (14 shared papers)Takayuki Yoshino (11 shared papers)Daniel J. Sargent (10 shared papers)Alfredo Falcone (13 shared papers)Antoine Adenis (13 shared papers)Olivier Bouché (13 shared papers)
- Journals
- Journal of Clinical Oncology (36 papers)Annals of Oncology (12 papers)Cancer Research (4 papers)European Journal of Cancer (2 papers)Targeted Oncology (2 papers)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Dirk Laurent
76 papers receiving 4.6k citations
Dirk Laurent's Hit Papers
Peers
Comparison fields: 5 of 86
- Oncology 2.5k
- Hepatology 643
- Cancer Research 814
- Gastroenterology 196
- Pathology and Forensic Medicine 615
Countries citing papers authored by Dirk Laurent
This map shows the geographic impact of Dirk Laurent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Laurent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Laurent more than expected).
Fields of papers citing papers by Dirk Laurent
This network shows the impact of papers produced by Dirk Laurent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Laurent. The network helps show where Dirk Laurent may publish in the future.
Co-authors
The 25 scholars most cited alongside Dirk Laurent, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial Hit paper breakdown → | 2012 | 2091 |
| 2 | 2015 | 232 | |
| 3 | 2005 | 178 | |
| 4 | 2005 | 161 | |
| 5 | 2011 | 139 | |
| 6 | 2005 | 128 | |
| 7 | 2011 | 125 | |
| 8 | 2020 | 119 | |
| 9 | 2011 | 117 | |
| 10 | 2005 | 95 | |
| 11 | 2004 | 88 | |
| 12 | 2003 | 86 | |
| 13 | 2007 | 81 | |
| 14 | 2004 | 66 | |
| 15 | 2006 | 65 | |
| 16 | 2006 | 60 | |
| 17 | 2019 | 59 | |
| 18 | 2011 | 53 | |
| 19 | 2007 | 52 | |
| 20 | 2005 | 48 |
About Dirk Laurent
Dirk Laurent is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Gastroenterology, having authored 77 papers that have together received 4.7k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (33 papers), Cancer Treatment and Pharmacology (23 papers), Cancer, Lipids, and Metabolism (14 papers), Angiogenesis and VEGF in Cancer (12 papers), Lung Cancer Treatments and Mutations (9 papers), Gastrointestinal Tumor Research and Treatment (8 papers), Gastric Cancer Management and Outcomes (8 papers) and Cancer, Hypoxia, and Metabolism (8 papers). The work is most often cited by research in Oncology (2.5k citations), Hepatology (643 citations), Cancer Research (814 citations), Gastroenterology (196 citations) and Pathology and Forensic Medicine (615 citations). Dirk Laurent has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Eric Van Cutsem, Heinz‐Josef Lenz, Salvatore Siena, Takayuki Yoshino, Daniel J. Sargent, Alfredo Falcone, Antoine Adenis, Olivier Bouché, Yves Humblet and Laurent Mineur. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, European Journal of Cancer and Targeted Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.